Search results
Results from the WOW.Com Content Network
The standards that are in effect since 1 December 2010, [4] are the Indian Pharmacopoeia 2010 (IP 2010). The Pharmacopoeia 2014 was released by Health Minister Ghulam Nabi Azad on 4 November 2013. [5] The Pharmacopoeia 2018 was released by Secretary, Ministry of Health & Family Welfare, Government of India. [5]
Many developed countries set up their pharmacovigilance programs following the Thalidomide scandal in the 1960s. [2] India set up its program in the 1980s. [2] This general concept of drug safety monitoring went through different forms, but the Central Drugs Standard Control Organisation established the present Pharmacovigilance Program of India in 2010. [2]
Current events; Random article; ... Download as PDF; Printable version; In other projects Wikimedia Commons; ... Indian Pharmacopoeia Commission;
The Ministry of Health and Family Welfare, also known by its abbreviation MoHFW, is an Indian government ministry charged with health policy in India. It is also responsible for all government programs relating to family planning in India. [2] [3] The Minister of Health and Family Welfare holds cabinet rank as a member of the Council of Ministers.
"Drugs and Cosmetics Rules, 1945" (PDF). Central Drugs Standard Control Organization.Archived from the original (PDF) on 31 October 2005.; A Review on the Current Classification and Regulatory Provisions for Medicines in Drug & Cosmetic Act, in the light of Present Day Context Recommendations for Drugs & Cosmetics Rules with context of Drug Schedules
Nitya Anand (1 January 1925 – 27 January 2024) was an Indian medicinal chemist who was the director of Central Drug Research Institute in Lucknow from 1974 to 1984. [1] [2] In 2005, Indian Pharmacopoeia Commission (IPC) appointed him chairman of its scientific committee. In 2012, he was awarded the Padma Shri by the Indian government. [3]
The Indian government has announced its plan to bring all medical devices, including implants and contraceptives under a review of the Central Drugs and Standard Control Organisation (CDSCO). Within the CDSCO, the Drug Controller General of India (DCGI) regulates pharmaceutical and medical devices and is positioning within the Ministry of ...
Schedule H is a class of prescription drugs in India appearing as an appendix to the Drugs and Cosmetics Rules, 1945 introduced in 1945. These are drugs which cannot be purchased over the counter without the prescription of a qualified doctor.